» Articles » PMID: 20694682

An Historical Overview of Drug Discovery

Overview
Specialty Molecular Biology
Date 2010 Aug 10
PMID 20694682
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Drug Discovery in modern times straddles three main periods. The first notable period can be traced to the nineteenth century where the basis of drug discovery relied on the serendipity of the medicinal chemists. The second period commenced around the early twentieth century when new drug structures were found, which contributed for a new era of antibiotics discovery. Based on these known structures, and with the development of powerful new techniques such as molecular modelling, combinatorial chemistry, and automated high-throughput screening, rapid advances occurred in drug discovery towards the end of the century. The period also was revolutionized by the emergence of recombinant DNA technology, where it became possible to develop potential drugs target candidates. With all the expansion of new technologies and the onset of the "Omics" revolution in the twenty-first century, the third period has kick-started with an increase in biopharmaceutical drugs approved by FDA/EMEA for therapeutic use.

Citing Articles

The role and application of bioinformatics techniques and tools in drug discovery.

Zhang S, Liu K, Liu Y, Hu X, Gu X Front Pharmacol. 2025; 16:1547131.

PMID: 40017606 PMC: 11865229. DOI: 10.3389/fphar.2025.1547131.


The Millennia-Long Development of Drugs Associated with the 80-Year-Old Artificial Intelligence Story: The Therapeutic Big Bang?.

Crouzet A, Lopez N, Riss Yaw B, Lepelletier Y, Demange L Molecules. 2024; 29(12).

PMID: 38930784 PMC: 11206022. DOI: 10.3390/molecules29122716.


Phenotypic drug discovery: a case for thymosin alpha-1.

Garaci E, Paci M, Matteucci C, Costantini C, Puccetti P, Romani L Front Med (Lausanne). 2024; 11:1388959.

PMID: 38903817 PMC: 11187271. DOI: 10.3389/fmed.2024.1388959.


Parallel Synthesis of Piperazine Tethered Thiazole Compounds with Antiplasmodial Activity.

Rayala R, Chaudhari P, Bunnell A, Roberts B, Chakrabarti D, Nefzi A Int J Mol Sci. 2023; 24(24).

PMID: 38139243 PMC: 10743568. DOI: 10.3390/ijms242417414.


Perspective on the challenges and opportunities of accelerating drug discovery with artificial intelligence.

Santa Maria Jr J, Wang Y, Camargo L Front Bioinform. 2023; 3:1121591.

PMID: 36909937 PMC: 9997711. DOI: 10.3389/fbinf.2023.1121591.